Journal article
Therapeutic potential of megadose vitamin C to reverse organ dysfunction in sepsis and COVID-19
CN May, R Bellomo, YR Lankadeva
British Journal of Pharmacology | Published : 2021
DOI: 10.1111/bph.15579
Abstract
Sepsis induced by bacteria or viruses can result in multiorgan dysfunction, which is a major cause of death in intensive care units. Current treatments are only supportive, and there are no treatments that reverse the pathophysiological effects of sepsis. Vitamin C has antioxidant, anti-inflammatory, anticoagulant and immune modulatory actions, so it is a rational treatment for sepsis. Here, we summarise data that support the use of megadose vitamin C as a treatment for sepsis and COVID-19. Megadose intravenous sodium ascorbate (150 g per 40 kg over 7 h) dramatically improved the clinical state and cardiovascular, pulmonary, hepatic and renal function and decreased body temperature, in a cli..
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
National Health and Medical Research Council of Australlia, Grant/Award Number: GNT1188514; National Heart Foundation of Australia, Grant/Award Number: 101853; Victorian Government Operational Infrastructure Support Grant